Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Glycated albumin (GA) is one of the proteins that replaces several sugar moieties and can be used as an indicator of diabetes mellitus. We developed a sensing system that uses GA in the early detection of diabetes mellitus. In this study, HYC acetylated (Ac-) at the N-terminals of the peptide was combined with wheat germ agglutinin (WGA) to recognize glucose moieties. The Ac-HYC-WGA was constructed as a GA-sensing probe. The tyrosine residues of YC exhibited an oxidation peak, and His-tag moieties were introduced to separate Ac-HYC-WGA in the synthesis of the probe. The Ac-HYC-WGA probe binds with the 1-2 molecules of Ac-HYC per WGA using matrix assisted laser desorption/ionization-time of flight (MALDI-TOF)-MS. Next, the functions of Ac-HYC-WGA were evaluated using voltammetry. The number of electron-transfers was calculated based on the relationship between the peak potential and logarithm of scan rate and was 3.03. In the electrochemical measurements with mannose and bovine serum albumin, the peak currents were similar to that of GA alone. By contrast, a decrease in the peak current was suppressed when glucose was added to the solution containing the probe. As a result, Ac-HYC-WGA was selectively bound to the glucose moieties of GA. The calibration curve via differential pulse voltammetry was proportional to the concentrations of GA and ranged from 1.0 × 10 to 2.0 × 10 M with a detection limit of 3.3 × 10 M.

Download full-text PDF

Source
http://dx.doi.org/10.1248/cpb.c23-00702DOI Listing

Publication Analysis

Top Keywords

glycated albumin
8
diabetes mellitus
8
glucose moieties
8
probe
5
ac-hyc-wga
5
construction biosensing
4
biosensing system
4
system glycated
4
albumin electron
4
electron transfer
4

Similar Publications

There is a lack of longitudinal data on type 2 diabetes (T2D) in low- and middle-income countries. We leveraged the electronic health records (EHR) system of a publicly funded academic institution to establish a retrospective cohort with longitudinal data to facilitate benchmarking, surveillance, and resource planning of a multi-ethnic T2D population in Malaysia. This cohort included 15,702 adults aged ≥ 18 years with T2D who received outpatient care (January 2002-December 2020) from Universiti Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia.

View Article and Find Full Text PDF

CAR-T cell therapy has been proven effective in various autoimmune diseases, with most studies utilizing lentiviral-transduced CAR-T cells. In recent years, retroviral vector-transduced CAR-T cells-characterized by a high positivity rate, stable cell lines, and lower plasmid requirements-have attracted increasing attention. This article presents a complex case of a patient with SLE combined with APS and TBIRS.

View Article and Find Full Text PDF

Background: The prevalence of diabetes mellitus has surged fourfold globally over the past 30 years, creating a major health concern. Imeglimin, a novel oral antidiabetic agent, has shown promising results in the management of type 2 diabetes mellitus (T2DM).

Objectives: This systematic review aimed to evaluate the efficacy and safety of imeglimin in patients with T2DM based on available clinical studies.

View Article and Find Full Text PDF

Aim: This review aims to map the existing literature on the use of diabetes technology in people receiving dialysis, with a focus on utilization, accuracy, and effectiveness.

Methods: A scoping review was conducted using the Joanna Briggs Institute methodology, with systematic searches of Medline, Embase, and CINAHL for studies on diabetes technologies in dialysis populations.

Results: The search identified 1060 continuous glucose monitoring (CGM) and 1467 continuous subcutaneous insulin infusion or automated insulin delivery (CSII/AID) records, with 64 studies included.

View Article and Find Full Text PDF